3-Methyleneindoline | 7443-89-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 3-Methyleneindoline
• 英文别名: 3-methylidene-1,2-dihydroindole
• CAS: 7443-89-2
• 化学式: C₉H₉N
• 分子量: 131.17
• InChiKey: QIAQEGLHCKQHOC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] EPIMINOCYCLOALKYL(B)INDOLE DERIVATIVES AS SEROTONIN SUB-TYPE 6 (5-HT6) MODULATORS AND USES THEREOF<br/>[FR] DÉRIVÉS D'ÉPIMINOCYCLOALKYL(B)INDOLE UTILISÉS EN TANT QUE MODULATEURS DU RÉCEPTEUR DE LA SÉROTONINE DE SOUS-TYPE 6 (5-HT6) ET LEURS UTILISATIONS
  申请人：ALBANY MOLECULAR RES INC

  公开号：WO2011044134A1

  公开（公告）日：2011-04-14

  The present invention relates to epiminocycloalkyl[b]indole derivatives as serotonin sub-type 6 (5-HT6) modulators, pharmaceutical compositions including these compounds, and methods of preparation and use thereof. These compounds are useful in the treatment of central nervous system disorders including obesity, metabolic syndrome, cognition, and schizophrenia. The subject compounds have the structure of formula (I), with the substituents being described herein.

  本发明涉及作为5-羟色胺亚型6（5-HT6）调节剂的环氨基环巴[b]吲哚衍生物，包括这些化合物的药物组合物，以及其制备和使用方法。这些化合物在治疗包括肥胖、代谢综合征、认知和精神分裂症在内的中枢神经系统疾病中具有用途。所述化合物具有式（I）的结构，其中取代基如本文所述。
• [EN] POLYMERIZABLE COMPOUND AND OPTICALLY ANISOTROPIC BODY<br/>[FR] COMPOSÉ POLYMÉRISABLE ET CORPS OPTIQUEMENT ANISOTROPE
  申请人：DAINIPPON INK & CHEMICALS

  公开号：WO2017079867A1

  公开（公告）日：2017-05-18

  There is provided a polymerizable composition, by which discoloration or alignment defects are less likely to occur when a filmy polymer, which is obtained by adding a polymerizable compound to the polymerizable composition and polymerizing this composition, is irradiated with ultraviolet light. There are also provided a polymer obtained by polymerizing the polymerizable composition, and an optically anisotropic body using the polymer. The present invention provides a polymerizable low-wavelength dispersive or polymerizable reverse-wavelength dispersive compound having a partial structure represented by Formula (Z-0). Further, the present invention provides a composition containing the compound; a polymer obtained by polymerizing the composition; and an optically anisotropic body obtained by using the polymer.

  提供一种可聚合的组合物，通过该组合物得到的薄膜聚合物在紫外光照射时，不太容易发生变色或排列缺陷。还提供了通过聚合该聚合物组合物得到的聚合物，以及使用该聚合物的光学各向异性体。本发明提供了一种具有由式（Z-0）表示的部分结构的可聚合低波长色散或可聚合反波长色散化合物。此外，本发明提供了一种含有该化合物的组合物；通过聚合该组合物得到的聚合物；以及通过使用该聚合物得到的光学各向异性体。
• Polypeptides and biosynthetic pathways for the production of monatin and its precursors
  申请人：Abraham W. Timothy

  公开号：US20050244937A1

  公开（公告）日：2005-11-03

  Methods and compositions that can be used to make monatin from glucose, tryptophan, indole-3-lactic acid, indole-3-pyruvate, and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid, are provided. Methods are also disclosed for produding the indole-3-pyruvate and 2-hydroxy 2-(indol-3-ylmethyl)-4-keto glutaric acid intermediates. Compositions provided include nucleic acid molecules, polypeptides, chemical structures, and cells. Methods include in vitro and in vivo processes, and the in vitro methods include chemical reactions.

  提供了从葡萄糖、色氨酸、吲哚-3-乳酸、吲哚-3-丙酮酸和2-羟基2-(吲哚-3-基甲基)-4-酮戊酸制备莫纳丁的方法和组合物。还公开了制备吲哚-3-丙酮酸和2-羟基2-(吲哚-3-基甲基)-4-酮戊酸中间体的方法。提供的组合物包括核酸分子、多肽、化学结构和细胞。方法包括体外和体内过程，其中体外方法包括化学反应。
• Beverage compositions comprising monatin and methods of making same
  申请人：Abraham W. Timothy

  公开号：US20050106305A1

  公开（公告）日：2005-05-19

  The present invention relates to novel beverage compositions comprising monatin and methods for making such compositions. The present invention also relates to beverage compositions comprising specific monatin stereoisomers, specific blends of monatin stereoisomers, and/or monatin produced via a biosynthetic pathway in vivo (e.g., inside cells) or in vitro.

  本发明涉及包含莫纳丁的新型饮料组合物及其制备方法。本发明还涉及包含特定莫纳丁立体异构体、特定莫纳丁立体异构体混合物和/或通过体内（例如细胞内）或体外生物合成途径产生的莫纳丁的饮料组合物。
• Monatin tabletop sweetener compositions and methods of making same
  申请人：Abraham W. Timothy

  公开号：US20050112260A1

  公开（公告）日：2005-05-26

  The present invention relates to novel sweetener compositions comprising monatin and methods for making such compositions. The present invention also relates to sweetener compositions comprising specific monatin stereoisomers, specific blends of monatin stereoisomers, and/or monatin produced via a biosynthetic pathway in vivo (e.g., inside cells) or in vitro.

  本发明涉及包含莫纳丁的新型甜味剂组合物及制造此类组合物的方法。本发明还涉及包含特定莫纳丁立体异构体、特定莫纳丁立体异构体混合物和/或在体内（例如细胞内）或体外通过生物合成途径产生的莫纳丁的甜味剂组合物。